\-\ Texto\\:\\ \ \(0\)\
\-\ afebrile\\,\\ vss\\.\ \(0\)\
\-\ \\(\\+\\)\\ left\\ cheek\\/neck\\ swelling\\.\ \(1\)\
\-\ exam\\ otherwise\\ benign\\.\ \(0\)\
\-\ observation\\ and\\ routine\\ follow\\-up\\ in\\ pediatric\\ and\\ ent\\ clinics\\.\\ hemangioma\\ is\\ a\\ clinical\\ diagnosis\\ given\\ the\\ appropriate\\ age\\ group\\ and\\ presentation\\.\\ \\ imaging\\ is\\ used\\ primarily\\ to\\ rule\\ out\\ other\\ rare\\ causes\\ \\(e\\.g\\.\\ other\\ types\\ of\\ tumors\\,\\ vascular\\ malformations\\)\\.\ \(0\)\
\-\ multiplanar\\,\\ bilateral\\ gray\\ scale\\ and\\ limited\\ doppler\\ ultrasound\\ of\\ the\\ neck\\ reveals\\ a\\ 3\\.1\\ x\\ 2\\.3\\ cm\\ heterogeneous\\,\\ hypervascular\\,\\ predominantly\\ isoechoic\\ mass\\ in\\ the\\ left\\ parotid\\ gland\\.\\ \\ subsequent\\ magnetic\\ resonance\\ imaging\\ with\\ and\\ without\\ contrast\\ demonstrates\\ a\\ lobular\\ mass\\ centered\\ in\\ left\\ parotid\\ gland\\,\\ with\\ extension\\ into\\ the\\ left\\ infratemporal\\ fossa\\ and\\ parapharyngeal\\ space\\ along\\ the\\ lateral\\ border\\ of\\ the\\ left\\ internal\\ jugular\\ vein\\.\\ there\\ is\\ additional\\ insinuation\\ of\\ the\\ mass\\ between\\ the\\ left\\ sternocleidomastoid\\ muscle\\ and\\ levator\\ scapularis\\ muscle\\.\\ \\ contrast\\ enhancement\\ is\\ intense\\ and\\ homogeneous\\,\\ and\\ there\\ are\\ numerous\\ prominent\\ flow\\ voids\\ within\\ this\\ mass\\.\ \(0\)\
\-\ infantile\\ hemangioma\\,\\ parotid\ \(0\)\
\-\ \\(1\\)\\ infantile\\ hemangioma\\ is\\ the\\ most\\ common\\ infant\\ tumor\\ and\\ most\\ common\\ pediatric\\ tumor\\ of\\ the\\ parotid\\ gland\\.\\ \ \(0\)\
\-\ \\(2\\)\\ malignant\\ tumors\\ \\(rhabdomyosarcoma\\,\\ metastatic\\ tumors\\,\\ teratoma\\,\\ primary\\ parotid\\ cancer\\,\\ and\\ lymphoproliferative\\ disease\\)\\,\\ which\\ account\\ for\\ 20\\%\\ of\\ parotid\\ neoplasms\\,\\ should\\ be\\ ruled\\ out\\ if\\ necessary\\,\\ especially\\ in\\ older\\ children\\.\\ \\(3\\)\\ benign\\ tumors\\ \\(warthin\\ tumor\\,\\ adenomas\\,\\ cystic\\ hygroma\\/lymphangioma\\,\\ lipoblastoma\\,\\ etc\\.\\)\\ account\\ for\\ 80\\%\\ of\\ parotid\\ neoplasms\\.\\ \ \(0\)\
\-\ \\(4\\)\\ inflammatory\\ or\\ infectious\\ causes\\ \\(cervical\\ adenitis\\,\\ abscess\\,\\ tuberculosis\\,\\ and\\ sarcoidosis\\)\\ are\\ unlikely\\ in\\ a\\ healthy\\ two\\ month\\ old\\ infant\\.\\ \ \(0\)\
\-\ \\(5\\)\\ miscellaneous\\ rare\\ causes\\ \\(developmental\\ cysts\\ or\\ fistulas\\,\\ congenital\\ fibromatosis\\ of\\ sternocleidomastoid\\,\\ fibrodysplasia\\ ossificans\\ progressiva\\)\\ are\\ at\\ the\\ bottom\\ of\\ the\\ differential\\.\ \(0\)\
\-\ the\\ patient\\ is\\ a\\ healthy\\ 2\\ month\\ old\\ baby\\ girl\\ with\\ a\\ rapidly\\ enlarging\\ neck\\ mass\\.\\ \\ the\\ mass\\ was\\ not\\ noted\\ on\\ initial\\ newborn\\ exam\\ at\\ birth\\.\\ \\ she\\ was\\ an\\ appropriate\\ for\\ gestational\\ age\\ baby\\ delivered\\ via\\ cesarean\\ section\\ at\\ 37\\ weeks\\ after\\ failure\\ to\\ progress\\ with\\ induction\\,\\ in\\ a\\ mother\\ with\\ preeclampsia\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ parotid\\:\\ 0\\.4758048265270813\ \(0\)\
\-\ tumors\\:\\ 0\\.168456672509359\ \(0\)\
\-\ the\\:\\ 0\\.15996528935892196\ \(0\)\
\-\ hemangioma\\:\\ 0\\.14450579175819556\ \(0\)\
\-\ and\\:\\ 0\\.14199297966943045\ \(0\)\
\-\ sternocleidomastoid\\:\\ 0\\.14140384816311877\ \(0\)\
\-\ gland\\:\\ 0\\.13955168125773373\ \(0\)\
\-\ mass\\:\\ 0\\.13123818336608345\ \(0\)\
\-\ infantile\\:\\ 0\\.13089859747676275\ \(0\)\
\-\ causes\\:\\ 0\\.12980787402576935\ \(0\)\
\-\ left\\:\\ 0\\.1172024486845294\ \(0\)\
\-\ account\\:\\ 0\\.11661388899765424\ \(0\)\
\-\ neoplasms\\:\\ 0\\.10672644076732507\ \(0\)\
\-\ neck\\:\\ 0\\.10508853683994274\ \(0\)\
\-\ baby\\:\\ 0\\.10325273576825954\ \(0\)\
\-\ pediatric\\:\\ 0\\.10251588258704852\ \(0\)\
\-\ infant\\:\\ 0\\.10111865837297038\ \(0\)\
\-\ of\\:\\ 0\\.10085547056303033\ \(0\)\
\-\ appropriate\\:\\ 0\\.10061879033831103\ \(0\)\
\-\ healthy\\:\\ 0\\.09715123826470341\ \(0\)\
\-\ is\\:\\ 0\\.09409157053358384\ \(0\)\
\-\ insinuation\\:\\ 0\\.09157639343543367\ \(0\)\
\-\ scapularis\\:\\ 0\\.09157639343543367\ \(0\)\
\-\ tumor\\:\\ 0\\.08985599702413748\ \(0\)\
\-\ lipoblastoma\\:\\ 0\\.08750613283727719\ \(0\)\
\-\ fibrodysplasia\\:\\ 0\\.08750613283727719\ \(0\)\
\-\ rare\\:\\ 0\\.08645713431408156\ \(0\)\
\-\ in\\:\\ 0\\.08547142010849355\ \(0\)\
\-\ progressiva\\:\\ 0\\.08461823698414224\ \(0\)\
\-\ preeclampsia\\:\\ 0\\.08461823698414224\ \(0\)\
\-\ muscle\\:\\ 0\\.08132138330040874\ \(0\)\
\-\ lymphoproliferative\\:\\ 0\\.08054797638598576\ \(0\)\
\-\ miscellaneous\\:\\ 0\\.08054797638598576\ \(0\)\
\-\ infratemporal\\:\\ 0\\.07900053512474524\ \(0\)\
\-\ warthin\\:\\ 0\\.07900053512474524\ \(0\)\
\-\ benign\\:\\ 0\\.07867196744952779\ \(0\)\
\-\ levator\\:\\ 0\\.07647771578782928\ \(0\)\
\-\ induction\\:\\ 0\\.07647771578782928\ \(0\)\
\-\ out\\:\\ 0\\.07527987426642621\ \(0\)\
\-\ clinics\\:\\ 0\\.07204237867345381\ \(0\)\
\-\ parapharyngeal\\:\\ 0\\.07204237867345381\ \(0\)\
\-\ cesarean\\:\\ 0\\.07204237867345381\ \(0\)\
\-\ age\\:\\ 0\\.07190086298970079\ \(0\)\
\-\ isoechoic\\:\\ 0\\.07134979388440187\ \(0\)\
\-\ fibromatosis\\:\\ 0\\.07134979388440187\ \(0\)\
\-\ bottom\\:\\ 0\\.07009334394846506\ \(0\)\
\-\ month\\:\\ 0\\.0696677864016492\ \(0\)\
\-\ adenitis\\:\\ 0\\.06897680565443925\ \(0\)\
\-\ fistulas\\:\\ 0\\.06846189803126693\ \(0\)\
\-\ ossificans\\:\\ 0\\.06705889807937052\ \(0\)\
\-\ adenomas\\:\\ 0\\.0666316634834029\ \(0\)\
\-\ vss\\:\\ 0\\.06582815493803519\ \(0\)\
\-\ are\\:\\ 0\\.06518639036829706\ \(0\)\
\-\ multiplanar\\:\\ 0\\.06508422222216237\ \(0\)\
\-\ common\\:\\ 0\\.06494963668992355\ \(0\)\
\-\ at\\:\\ 0\\.06488715660205392\ \(0\)\
\-\ delivered\\:\\ 0\\.06439163743311044\ \(0\)\
\-\ ent\\:\\ 0\\.061013961624005894\ \(0\)\
\-\ hypervascular\\:\\ 0\\.06054697054911958\ \(0\)\
\-\ imaging\\:\\ 0\\.060187545306900875\ \(0\)\
\-\ resonance\\:\\ 0\\.06010074162807909\ \(0\)\
\-\ centered\\:\\ 0\\.05967350703211147\ \(0\)\
\-\ most\\:\\ 0\\.05960305240427567\ \(0\)\
\-\ other\\:\\ 0\\.059475443951724286\ \(0\)\
\-\ magnetic\\:\\ 0\\.05906492689901714\ \(0\)\
\-\ jugular\\:\\ 0\\.05906492689901714\ \(0\)\
\-\ voids\\:\\ 0\\.05867878322332203\ \(0\)\
\-\ progress\\:\\ 0\\.05830694449882712\ \(0\)\
\-\ lobular\\:\\ 0\\.05812606577087095\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.057948388604991345\ \(0\)\
\-\ malformations\\:\\ 0\\.05777380163393559\ \(0\)\
\-\ exam\\:\\ 0\\.05765269136437381\ \(0\)\
\-\ ruled\\:\\ 0\\.05726755162044695\ \(0\)\
\-\ rapidly\\:\\ 0\\.05726755162044695\ \(0\)\
\-\ scale\\:\\ 0\\.05710432041735104\ \(0\)\
\-\ newborn\\:\\ 0\\.0564767099509631\ \(0\)\
\-\ etc\\:\\ 0\\.056325752252032145\ \(0\)\
\-\ with\\:\\ 0\\.05606429537925512\ \(0\)\
\-\ contrast\\:\\ 0\\.05564608220397432\ \(0\)\
\-\ gestational\\:\\ 0\\.055603246433955\ \(0\)\
\-\ primarily\\:\\ 0\\.054929268689722574\ \(0\)\
\-\ group\\:\\ 0\\.05442088168893346\ \(0\)\
\-\ intense\\:\\ 0\\.05405580517271446\ \(0\)\
\-\ observation\\:\\ 0\\.053703541035779116\ \(0\)\
\-\ enlarging\\:\\ 0\\.05347538353720267\ \(0\)\
\-\ types\\:\\ 0\\.053252296627346755\ \(0\)\
\-\ older\\:\\ 0\\.05314258517678766\ \(0\)\
\-\ section\\:\\ 0\\.05220567270395303\ \(0\)\
\-\ for\\:\\ 0\\.05206814935785375\ \(0\)\
\-\ doppler\\:\\ 0\\.05125794129352426\ \(0\)\
\-\ birth\\:\\ 0\\.05116790931957951\ \(0\)\
\-\ unlikely\\:\\ 0\\.0507294772904308\ \(0\)\
\-\ border\\:\\ 0\\.050644042750871886\ \(0\)\
\-\ homogeneous\\:\\ 0\\.05055932918648519\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.05039201701667978\ \(0\)\
\-\ predominantly\\:\\ 0\\.05014616396605961\ \(0\)\
\-\ teratoma\\:\\ 0\\.049518553499671665\ \(0\)\
\-\ developmental\\:\\ 0\\.049518553499671665\ \(0\)\
\-\ afebrile\\:\\ 0\\.049442790892459385\ \(0\)\
\-\ gray\\:\\ 0\\.04899984413519049\ \(0\)\
\-\ mother\\:\\ 0\\.048927883269287056\ \(0\)\
\-\ 37\\:\\ 0\\.048785490842041285\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.04850662574870055\ \(0\)\
\-\ numerous\\:\\ 0\\.048370045440389316\ \(0\)\
\-\ necessary\\:\\ 0\\.04790613791576715\ \(0\)\
\-\ children\\:\\ 0\\.046919971555543435\ \(0\)\
\-\ via\\:\\ 0\\.04680324352164126\ \(0\)\
\-\ infectious\\:\\ 0\\.046075903367903126\ \(0\)\
\-\ limited\\:\\ 0\\.04570504597170519\ \(0\)\
\-\ there\\:\\ 0\\.04556973416299337\ \(0\)\
\-\ rule\\:\\ 0\\.04544829290151519\ \(0\)\
\-\ especially\\:\\ 0\\.04529733520258423\ \(0\)\
\-\ prominent\\:\\ 0\\.045099525889787134\ \(0\)\
\-\ fossa\\:\\ 0\\.0449536855841609\ \(0\)\
\-\ 80\\:\\ 0\\.04466821143283835\ \(0\)\
\-\ additional\\:\\ 0\\.04439063159624426\ \(0\)\
\-\ routine\\:\\ 0\\.044345105451066576\ \(0\)\
\-\ reveals\\:\\ 0\\.04355908253597953\ \(0\)\
\-\ failure\\:\\ 0\\.04347542790348143\ \(0\)\
\-\ cysts\\:\\ 0\\.04339246463948555\ \(0\)\
\-\ subsequent\\:\\ 0\\.04335123871786409\ \(0\)\
\-\ used\\:\\ 0\\.04286929827639367\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.041445860249288\ \(0\)\
\-\ congenital\\:\\ 0\\.041144179849273536\ \(0\)\
\-\ vein\\:\\ 0\\.04104560133723092\ \(0\)\
\-\ cervical\\:\\ 0\\.04101295578713971\ \(0\)\
\-\ otherwise\\:\\ 0\\.040819281011809073\ \(0\)\
\-\ malignant\\:\\ 0\\.040819281011809073\ \(0\)\
\-\ extension\\:\\ 0\\.04053559971617921\ \(0\)\
\-\ girl\\:\\ 0\\.040169413299156825\ \(0\)\
\-\ was\\:\\ 0\\.039913614948613424\ \(0\)\
\-\ or\\:\\ 0\\.039841725888113626\ \(0\)\
\-\ presentation\\:\\ 0\\.039419061422153415\ \(0\)\
\-\ given\\:\\ 0\\.03939129239253417\ \(0\)\
\-\ inflammatory\\:\\ 0\\.03872091667848357\ \(0\)\
\-\ internal\\:\\ 0\\.03859205100889108\ \(0\)\
\-\ swelling\\:\\ 0\\.038540964395805705\ \(0\)\
\-\ initial\\:\\ 0\\.03841437384301148\ \(0\)\
\-\ along\\:\\ 0\\.03836418124941336\ \(0\)\
\-\ flow\\:\\ 0\\.0381413694384957\ \(0\)\
\-\ cancer\\:\\ 0\\.0381413694384957\ \(0\)\
\-\ space\\:\\ 0\\.038116915107751864\ \(0\)\
\-\ vascular\\:\\ 0\\.03780431386944775\ \(0\)\
\-\ should\\:\\ 0\\.0373642631193722\ \(0\)\
\-\ between\\:\\ 0\\.03720688143078721\ \(0\)\
\-\ differential\\:\\ 0\\.03720688143078721\ \(0\)\
\-\ 20\\:\\ 0\\.036942695188983236\ \(0\)\
\-\ abscess\\:\\ 0\\.03677035622998615\ \(0\)\
\-\ clinical\\:\\ 0\\.03629075214696698\ \(0\)\
\-\ ultrasound\\:\\ 0\\.03532103179437769\ \(0\)\
\-\ primary\\:\\ 0\\.03521071752155113\ \(0\)\
\-\ cystic\\:\\ 0\\.034487703797996566\ \(0\)\
\-\ weeks\\:\\ 0\\.03431898557765226\ \(0\)\
\-\ she\\:\\ 0\\.03408744488593949\ \(0\)\
\-\ two\\:\\ 0\\.034006029210094296\ \(0\)\
\-\ old\\:\\ 0\\.03389523403118739\ \(0\)\
\-\ if\\:\\ 0\\.033271367792784924\ \(0\)\
\-\ enhancement\\:\\ 0\\.03295972642614223\ \(0\)\
\-\ cm\\:\\ 0\\.0328869306190584\ \(0\)\
\-\ metastatic\\:\\ 0\\.031406024798121934\ \(0\)\
\-\ bilateral\\:\\ 0\\.030775380407175652\ \(0\)\
\-\ into\\:\\ 0\\.030440154743025555\ \(0\)\
\-\ noted\\:\\ 0\\.03036088813303593\ \(0\)\
\-\ without\\:\\ 0\\.030204208286559484\ \(0\)\
\-\ diagnosis\\:\\ 0\\.029684859832610898\ \(0\)\
\-\ demonstrates\\:\\ 0\\.02876843111113144\ \(0\)\
\-\ to\\:\\ 0\\.02863139704646288\ \(0\)\
\-\ lateral\\:\\ 0\\.028418490431631763\ \(0\)\
\-\ after\\:\\ 0\\.02777933838687604\ \(0\)\
\-\ within\\:\\ 0\\.026373684402722676\ \(0\)\
\-\ which\\:\\ 0\\.026038166799219244\ \(0\)\
\-\ disease\\:\\ 0\\.024037075547926643\ \(0\)\
\-\ be\\:\\ 0\\.02322940883979074\ \(0\)\
\-\ not\\:\\ 0\\.022606166590090248\ \(0\)\
\-\ an\\:\\ 0\\.021897272296547376\ \(0\)\
\-\ this\\:\\ 0\\.019676681872473303\ \(0\)\
\-\ patient\\:\\ 0\\.01862485860040327\ \(0\)\
\-\ on\\:\\ 0\\.017294482602433926\ \(0\)\
